Xinghai Li

Company: Hinova Pharmaceuticals, Inc.

Job title: CSO

Bio:

Seminar: Discovery of HP518, a Novel AR PROTAC Degrader for mCRPC Treatment

For more information on this session, please download the full event guide.

Day: Day One